pharmaphorum February 13, 2024
A judge in a federal court in Texas has thrown out a lawsuit brought by the pharma industry challenging legislation introduced by the Biden administration that allows Medicare to negotiate the prices of some medicines.
Judge David Ezra in the Western District of Texas court dismissed a lawsuit brought by the Pharmaceutical Research and Manufacturers of America (PhRMA) trade organisation, claiming that the negotiations – introduced as part of the Inflation Reduction Act of 2022 – are unconstitutional.
He ruled (PDF) against PhRMA and co-plaintiffs the National Infusion Center Association (NICA) and the Global Colon Cancer Association (GCCA), saying NICA was the only plaintiff resident in Texas, so the complaints brought by PhRMA and GCCA were outside its jurisdiction.
Moreover,...
Today's Sponsors
Today's Sponsor